BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tang H, Li C, Zhang Y, Zheng H, Cheng Y, Zhu J, Chen X, Zhu Z, Piao JG, Li F. Targeted Manganese doped silica nano GSH-cleaner for treatment of Liver Cancer by destroying the intracellular redox homeostasis. Theranostics 2020;10:9865-87. [PMID: 32863964 DOI: 10.7150/thno.46771] [Cited by in Crossref: 45] [Cited by in F6Publishing: 49] [Article Influence: 15.0] [Reference Citation Analysis]
Number Citing Articles
1 Fan H, Guo Z. Tumor microenvironment-responsive manganese-based nanomaterials for cancer treatment. Coordination Chemistry Reviews 2023;480:215027. [DOI: 10.1016/j.ccr.2023.215027] [Reference Citation Analysis]
2 Hamida RS, Albasher G, Bin-meferij MM. Apoptotic Responses Mediated by Nostoc-Synthesized Silver Nanoparticles against Ehrlich Ascites Carcinoma Tumor-Bearing Mice. Journal of Nanomaterials 2023;2023:1-13. [DOI: 10.1155/2023/4648571] [Reference Citation Analysis]
3 Wang C, Wang J, Pan X, Yu S, Chen M, Gao Y, Song Z, Hu H, Zhao X, Chen D, Han F, Qiao M. Reversing ferroptosis resistance by MOFs through regulation intracellular redox homeostasis. Asian J Pharm Sci 2023;18:100770. [PMID: 36660553 DOI: 10.1016/j.ajps.2022.11.004] [Reference Citation Analysis]
4 Bariana M, Cassella E, Rateshwar J, Ouk S, Liou HC, Heller C, Colorado I, Feinman R, Makhdoom A, Siegel DS, Heller G, Tuckett A, Mondello P, Zakrzewski JL. Inhibition of NF-κB DNA Binding Suppresses Myeloma Growth via Intracellular Redox and Tumor Microenvironment Modulation. Mol Cancer Ther 2022;21:1798-809. [PMID: 36190955 DOI: 10.1158/1535-7163.MCT-22-0257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu M, Ling W, Wei J, Liao R, Sun H, Li D, Zhao Y, Zhao L. Biomimetic photosensitizer nanocrystals trigger enhanced ferroptosis for improving cancer treatment. J Control Release 2022;352:1116-33. [PMID: 36402233 DOI: 10.1016/j.jconrel.2022.11.026] [Reference Citation Analysis]
6 Liang X, Liu P, Li W, Binh Vong L, Wang T, Geng L, Zhou Y, Wang S, Lu Q, Tan F, Wang X, Li N. Dysfunction of DNA repair for boosted tumor cell cycle arrest based on NIR-II biodegradable Te-prussian blue nanorod. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140870] [Reference Citation Analysis]
7 Cao Y, Zhang S, Lv Z, Yin N, Zhang H, Song P, Zhang T, Chen Y, Xu H, Wang Y, Liu X, Zhao G, Zhang H. An Intelligent Nanoplatform for Orthotopic Glioblastoma Therapy by Nonferrous Ferroptosis. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202209227] [Reference Citation Analysis]
8 Si P, Yu W, Li C, Chen H, Zhang E, Gu J, Wang R, Shi J. Oxygen-independent alkyl radical nanogenerator enhances breast cancer therapy. Nanomedicine 2022;48:102630. [PMID: 36435366 DOI: 10.1016/j.nano.2022.102630] [Reference Citation Analysis]
9 Fu Z, Du H, Meng S, Yao M, Zhao P, Li X, Zheng X, Yuan Z, Yang H, Cai K, Dai L. Tumor-targeted dual-starvation therapy based on redox-responsive micelle nanosystem with co-loaded LND and BPTES. Mater Today Bio 2022;16:100449. [PMID: 36238964 DOI: 10.1016/j.mtbio.2022.100449] [Reference Citation Analysis]
10 Yang W, Yue H, Lu G, Wang W, Deng Y, Ma G, Wei W. Advances in Delivering Oxidative Modulators for Disease Therapy. Research 2022;2022:1-24. [DOI: 10.34133/2022/9897464] [Reference Citation Analysis]
11 Yun T, Liu Z, Wang J, Wang R, Zhu L, Zhu Z, Wang X. Microenvironment immune response induced by tumor ferroptosis—the application of nanomedicine. Front Oncol 2022;12:1019654. [DOI: 10.3389/fonc.2022.1019654] [Reference Citation Analysis]
12 Peng Y, Li N, Tang F, Qian C, Jia T, Liu J, Xu Y. Corosolic acid sensitizes ferroptosis by upregulating HERPUD1 in liver cancer cells. Cell Death Discov 2022;8:376. [PMID: 36038536 DOI: 10.1038/s41420-022-01169-0] [Reference Citation Analysis]
13 Li F, Long H, Zhou Z, Luo H, Xu S, Gao L. System Xc−/GSH/GPX4 axis: An important antioxidant system for the ferroptosis in drug-resistant solid tumor therapy. Front Pharmacol 2022;13:910292. [DOI: 10.3389/fphar.2022.910292] [Reference Citation Analysis]
14 Li L, Wang X, Xu H, Liu X, Xu K. Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma. Front Mol Biosci 2022;9:947208. [DOI: 10.3389/fmolb.2022.947208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Xia M, Guo Z, Liu X, Wang Y, Xiao C. A glutathione-responsive sulfur dioxide polymer prodrug selectively induces ferroptosis in gastric cancer therapy. Biomater Sci 2022. [PMID: 35727040 DOI: 10.1039/d2bm00678b] [Reference Citation Analysis]
16 Aschner M, Skalny AV, Martins AC, Sinitskii AI, Farina M, Lu R, Barbosa F Jr, Gluhcheva YG, Santamaria A, Tinkov AA. Ferroptosis as a mechanism of non-ferrous metal toxicity. Arch Toxicol 2022. [PMID: 35727353 DOI: 10.1007/s00204-022-03317-y] [Reference Citation Analysis]
17 Pancewicz J, Niklińska WE, Chlanda A. Flake Graphene-Based Nanomaterial Approach for Triggering a Ferroptosis as an Attractive Theranostic Outlook for Tackling Non-Small Lung Cancer: A Mini Review. Materials (Basel) 2022;15:3456. [PMID: 35629488 DOI: 10.3390/ma15103456] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yu X, Wang X, Yamazaki A, Li X. Tumor microenvironment-regulated nanoplatforms for the inhibition of tumor growth and metastasis in chemo-immunotherapy. J Mater Chem B 2022. [PMID: 35439801 DOI: 10.1039/d2tb00337f] [Reference Citation Analysis]
19 Shi Z, Zheng J, Tang W, Bai Y, Zhang L, Xuan Z, Sun H, Shao C. Multifunctional Nanomaterials for Ferroptotic Cancer Therapy. Front Chem 2022;10:868630. [DOI: 10.3389/fchem.2022.868630] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Nie D, Zhu Y, Guo T, Yue M, Lin M. Research Advance in Manganese Nanoparticles in Cancer Diagnosis and Therapy. Front Mater 2022;9:857385. [DOI: 10.3389/fmats.2022.857385] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Yabbarov N, Nikolskaya E, Sokol M, Mollaeva M, Chirkina M, Seregina I, Gulyaev M, Pirogov Y, Petrov R. Synergetic Enhancement of Tumor Double-Targeted MRI Nano-Probe. Int J Mol Sci 2022;23:3119. [PMID: 35328540 DOI: 10.3390/ijms23063119] [Reference Citation Analysis]
22 Wu Y, Li Y, Lv G, Bu W. Redox dyshomeostasis strategy for tumor therapy based on nanomaterials chemistry. Chem Sci 2022;13:2202-17. [PMID: 35310479 DOI: 10.1039/d1sc06315d] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
23 Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, Zhang C, Zhou F, Chen J, Zhang L. Ferroptosis in cancer and cancer immunotherapy. Cancer Communications 2022;42:88-116. [DOI: 10.1002/cac2.12250] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 20.0] [Reference Citation Analysis]
24 Chen X, Fan X, Zhang Y, Wei Y, Zheng H, Bao D, Xu H, Piao J, Li F, Zheng H. Cooperative coordination-mediated multi-component self-assembly of “all-in-one” nanospike theranostic nano-platform for MRI-guided synergistic therapy against breast cancer. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.027] [Reference Citation Analysis]
25 Tong J, Li D, Meng H, Sun D, Lan X, Ni M, Ma J, Zeng F, Sun S, Fu J, Li G, Ji Q, Zhang G, Shen Q, Wang Y, Zhu J, Zhao Y, Wang X, Liu Y, Ouyang S, Sheng C, Shen F, Wang P. Targeting a novel inducible GPX4 alternative isoform to alleviate ferroptosis and treat metabolic-associated fatty liver disease. Acta Pharmaceutica Sinica B 2022. [DOI: 10.1016/j.apsb.2022.02.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
26 Wang Y, Liu T, Li X, Sheng H, Ma X, Hao L. Ferroptosis-Inducing Nanomedicine for Cancer Therapy. Front Pharmacol 2021;12:735965. [PMID: 34987385 DOI: 10.3389/fphar.2021.735965] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
27 da Cruz Schneid A, Albuquerque LJC, Mondo GB, Ceolin M, Picco AS, Cardoso MB. Colloidal stability and degradability of silica nanoparticles in biological fluids: a review. J Sol-Gel Sci Technol. [DOI: 10.1007/s10971-021-05695-8] [Reference Citation Analysis]
28 Jia W, Han Y, Mao X, Xu W, Zhang Y. Nanotechnology strategies for hepatocellular carcinoma diagnosis and treatment. RSC Adv 2022;12:31068-31082. [DOI: 10.1039/d2ra05127c] [Reference Citation Analysis]
29 Liang Q, Ma Y, Wang F, Sun M, Lin L, Li T, Sun Z, Duan J. Silica nanoparticles induce hepatocyte ferroptosis and liver injury via ferritinophagy. Environ Sci : Nano 2022;9:3014-3029. [DOI: 10.1039/d2en00116k] [Reference Citation Analysis]
30 Dabbour NM, Salama AM, Donia T, Al-deeb RT, Abd Elghane AM, Badry KH, Loutfy SA. Managing GSH elevation and hypoxia to overcome resistance of cancer therapies using functionalized nanocarriers. Journal of Drug Delivery Science and Technology 2022;67:103022. [DOI: 10.1016/j.jddst.2021.103022] [Reference Citation Analysis]
31 Xing Y, Wang L, Wang L, Huang J, Wang S, Xie X, Zhu J, Ding T, Cai K, Zhang J. Flower‐Like Nanozymes with Large Accessibility of Single Atom Catalysis Sites for ROS Generation Boosted Tumor Therapy. Adv Funct Materials 2022;32:2111171. [DOI: 10.1002/adfm.202111171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yu N, Qiu P, Ren Q, Wen M, Geng P, Macharia DK, Zhu M, Chen Z. Transforming a Sword into a Knife: Persistent Phototoxicity Inhibition and Alternative Therapeutical Activation of Highly-Photosensitive Phytochlorin. ACS Nano 2021;15:19793-805. [PMID: 34851096 DOI: 10.1021/acsnano.1c07241] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
33 Chen Y, Chen M, Zhai T, Zhou H, Zhou Z, Liu X, Yang S, Yang H. Glutathione-Responsive Chemodynamic Therapy of Manganese(III/IV) Cluster Nanoparticles Enhanced by Electrochemical Stimulation via Oxidative Stress Pathway. Bioconjug Chem 2021. [PMID: 34905922 DOI: 10.1021/acs.bioconjchem.1c00512] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Ren Z, Huo Y, Zhang Q, Chen S, Lv H, Peng L, Wei H, Wan C. Protective Effect of Lactiplantibacillus plantarum 1201 Combined with Galactooligosaccharide on Carbon Tetrachloride-Induced Acute Liver Injury in Mice. Nutrients 2021;13:4441. [PMID: 34959993 DOI: 10.3390/nu13124441] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
35 Luo L, Wang H, Tian W, Li X, Zhu Z, Huang R, Luo H. Targeting ferroptosis-based cancer therapy using nanomaterials: strategies and applications. Theranostics 2021;11:9937-52. [PMID: 34815796 DOI: 10.7150/thno.65480] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
36 Su X, Cao Y, Liu Y, Ouyang B, Ning B, Wang Y, Guo H, Pang Z, Shen S. Localized disruption of redox homeostasis boosting ferroptosis of tumor by hydrogel delivery system. Mater Today Bio 2021;12:100154. [PMID: 34778741 DOI: 10.1016/j.mtbio.2021.100154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
37 Guan Q, Zhou LL, Dong YB. Ferroptosis in cancer therapeutics: a materials chemistry perspective. J Mater Chem B 2021;9:8906-36. [PMID: 34505861 DOI: 10.1039/d1tb01654g] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
38 Zhou M, Luo Y, Zeng W, Yang X, Chen T, Zhang L, He X, Yi X, Li Y, Yi X. A Co-delivery System Based on a Dimeric Prodrug and Star-Shaped Polymeric Prodrug Micelles for Drug Delivery. Front Chem 2021;9:765021. [PMID: 34746097 DOI: 10.3389/fchem.2021.765021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
39 Xie C, Cen D, Wang H, Wang Y, Wu Y, Han G, Li X. Hierarchical nanoclusters with programmed disassembly for mitochondria-targeted tumor therapy with MR imaging. Biomater Sci 2021. [PMID: 34726680 DOI: 10.1039/d1bm01423d] [Reference Citation Analysis]
40 Zaffaroni N, Beretta GL. Nanoparticles for Ferroptosis Therapy in Cancer. Pharmaceutics 2021;13:1785. [PMID: 34834199 DOI: 10.3390/pharmaceutics13111785] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
41 Li X, Wang Q, Yu S, Zhang M, Liu X, Deng G, Liu Y, Wu S. Multifunctional MnO2-based nanoplatform-induced ferroptosis and apoptosis for synergetic chemoradiotherapy. Nanomedicine (Lond) 2021;16:2343-61. [PMID: 34523352 DOI: 10.2217/nnm-2021-0286] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
42 Niu B, Liao K, Zhou Y, Wen T, Quan G, Pan X, Wu C. Application of glutathione depletion in cancer therapy: Enhanced ROS-based therapy, ferroptosis, and chemotherapy. Biomaterials 2021;277:121110. [PMID: 34482088 DOI: 10.1016/j.biomaterials.2021.121110] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 35.5] [Reference Citation Analysis]
43 Xiong Y, Xiao C, Li Z, Yang X. Engineering nanomedicine for glutathione depletion-augmented cancer therapy. Chem Soc Rev 2021;50:6013-41. [PMID: 34027953 DOI: 10.1039/d0cs00718h] [Cited by in Crossref: 101] [Cited by in F6Publishing: 116] [Article Influence: 50.5] [Reference Citation Analysis]
44 Chowdhury MMH, Salazar CJJ, Nurunnabi M. Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomater Sci 2021;9:4821-42. [PMID: 34032223 DOI: 10.1039/d1bm00167a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
45 Geng P, Yu N, Liu X, Wen M, Ren Q, Qiu P, Macharia DK, Zhang H, Li M, Chen Z. GSH-Sensitive Nanoscale Mn3+-Sealed Coordination Particles as Activatable Drug Delivery Systems for Synergistic Photodynamic-Chemo Therapy. ACS Appl Mater Interfaces 2021;13:31440-51. [PMID: 34184531 DOI: 10.1021/acsami.1c06440] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
46 Jin Z, Yi X, Yang J, Zhou M, Wu P, Yan G. Liposome-Coated Arsenic-Manganese Complex for Magnetic Resonance Imaging-Guided Synergistic Therapy Against Carcinoma. Int J Nanomedicine 2021;16:3775-88. [PMID: 34113100 DOI: 10.2147/IJN.S313962] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
47 Zhao M, Zhang N, Yang R, Chen D, Zhao Y. Which is Better for Nanomedicines: Nanocatalysts or Single-Atom Catalysts? Adv Healthc Mater 2021;10:e2001897. [PMID: 33326185 DOI: 10.1002/adhm.202001897] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
48 Ma L, Zhang X, Yu K, Xu X, Chen T, Shi Y, Wang Y, Qiu S, Guo S, Cui J, Miao Y, Tian X, Du L, Yu Y, Xia J, Wang J. Targeting SLC3A2 subunit of system XC- is essential for m6A reader YTHDC2 to be an endogenous ferroptosis inducer in lung adenocarcinoma. Free Radic Biol Med 2021;168:25-43. [PMID: 33785413 DOI: 10.1016/j.freeradbiomed.2021.03.023] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 17.5] [Reference Citation Analysis]
49 Matsumoto KI, Mitchell JB, Krishna MC. Multimodal Functional Imaging for Cancer/Tumor Microenvironments Based on MRI, EPRI, and PET. Molecules 2021;26:1614. [PMID: 33799481 DOI: 10.3390/molecules26061614] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
50 Kong FH, Ye QF, Miao XY, Liu X, Huang SQ, Xiong L, Wen Y, Zhang ZJ. Current status of sorafenib nanoparticle delivery systems in the treatment of hepatocellular carcinoma. Theranostics 2021;11:5464-90. [PMID: 33859758 DOI: 10.7150/thno.54822] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
51 Liu Z, Wang L, Liu L, Lu T, Jiao D, Sun Y, Han X. The Identification and Validation of Two Heterogenous Subtypes and a Risk Signature Based on Ferroptosis in Hepatocellular Carcinoma. Front Oncol 2021;11:619242. [PMID: 33738257 DOI: 10.3389/fonc.2021.619242] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 16.5] [Reference Citation Analysis]
52 Yang RZ, Zheng HL, Xu WN, Zheng XF, Li B, Jiang LS, Jiang SD. Vascular endothelial cell-secreted exosomes facilitate osteoarthritis pathogenesis by promoting chondrocyte apoptosis. Aging (Albany NY) 2021;13:4647-62. [PMID: 33526719 DOI: 10.18632/aging.202506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
53 Zhang Z, Lu M, Chen C, Tong X, Li Y, Yang K, Lv H, Xu J, Qin L. Holo-lactoferrin: the link between ferroptosis and radiotherapy in triple-negative breast cancer. Theranostics 2021;11:3167-82. [PMID: 33537080 DOI: 10.7150/thno.52028] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
54 Cao Y, Zhang H. Recent advances in nano material-based application of liver neoplasms. Smart Materials in Medicine 2021;2:114-23. [DOI: 10.1016/j.smaim.2021.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
55 Zheng H, Jiang J, Xu S, Liu W, Xie Q, Cai X, Zhang J, Liu S, Li R. Nanoparticle-induced ferroptosis: detection methods, mechanisms and applications. Nanoscale 2021;13:2266-85. [DOI: 10.1039/d0nr08478f] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 14.0] [Reference Citation Analysis]
56 Yang Y, Lin J, Guo S, Xue X, Wang Y, Qiu S, Cui J, Ma L, Zhang X, Wang J. RRM2 protects against ferroptosis and is a tumor biomarker for liver cancer. Cancer Cell Int 2020;20:587. [PMID: 33372599 DOI: 10.1186/s12935-020-01689-8] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 11.7] [Reference Citation Analysis]
57 Pu F, Chen F, Zhang Z, Shi D, Zhong B, Lv X, Tucker AB, Fan J, Li AJ, Qin K, Hu D, Chen C, Wang H, He F, Ni N, Huang L, Liu Q, Wagstaff W, Luu HH, Haydon RC, Shen L, He T, Liu J, Shao Z. Ferroptosis as a novel form of regulated cell death: Implications in the pathogenesis, oncometabolism and treatment of human cancer. Genes & Diseases 2020. [DOI: 10.1016/j.gendis.2020.11.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]